BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Chemical substance: Darunavir

Presentation	Product	Chemical substance	Chapter	Items dispensed
Darunavir 800mg tablets 0503010ACAAAGAG	Darunavir	Darunavir	Infections	2
Darunavir 400mg tablets 0503010ACAAABAB	Darunavir	Darunavir	Infections	1
Darunavir 100mg/ml oral suspension sugar free 0503010ACAAAFAF	Darunavir	Darunavir	Infections	No data available
Darunavir 150mg tablets 0503010ACAAAEAE	Darunavir	Darunavir	Infections	No data available
Darunavir 300mg tablets 0503010ACAAAAAA	Darunavir	Darunavir	Infections	No data available
Darunavir 600mg tablets 0503010ACAAACAC	Darunavir	Darunavir	Infections	No data available
Darunavir 75mg tablets 0503010ACAAADAD	Darunavir	Darunavir	Infections	No data available
Prezista 100mg/ml oral suspension 0503010ACBBAFAF	Prezista	Darunavir	Infections	No data available
Prezista 150mg tablets 0503010ACBBAEAE	Prezista	Darunavir	Infections	No data available
Prezista 300mg tablets 0503010ACBBAAAA	Prezista	Darunavir	Infections	No data available
Prezista 400mg tablets 0503010ACBBABAB	Prezista	Darunavir	Infections	No data available
Prezista 600mg tablets 0503010ACBBACAC	Prezista	Darunavir	Infections	No data available
Prezista 75mg tablets 0503010ACBBADAD	Prezista	Darunavir	Infections	No data available
Prezista 800mg tablets 0503010ACBBAGAG	Prezista	Darunavir	Infections	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.